https://www.drugtargetreview.com/how-gpcr-agonists-including-antibodies-are-shaping-the-future-of-metabolic-care/644518.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/scientific-workflow-for-hypothesis-testing-in-drug-discovery-part-2-of-3/645024.article 2026-04-15T13:48:45.257Z https://www.drugtargetreview.com/non-invasive-eye-drops-provide-new-solution-for-dry-amd-patients/645120.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/new-research-shows-way-to-bypass-immunotherapy-resistance/645129.article 2026-03-12T14:26:39.930Z https://www.drugtargetreview.com/gene-linked-to-high-altitudes-could-transform-blood-cancer-therapy/645135.article 2026-03-13T12:10:46.787Z https://www.drugtargetreview.com/grant-to-fund-development-of-vaccines-to-prevent-dementia/645140.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/phage-therapy-a-step-forward-in-the-fight-against-antibiotic-resistance/645148.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/new-genetic-mechanism-could-lead-to-rna-therapies-for-mental-health/645157.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/innovative-lupus-treatment-under-investigation-at-virginia-tech/645161.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/new-painless-vaccine-technology-targets-viruses/645334.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/study-reveals-how-neurotransmitters-influence-brain-gene-expression/645340.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/lb-pharmaceuticals-announces-positive-schizophrenia-trial-data/645351.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/collaboration-aims-to-advance-automated-insulin-technology-for-diabetes/645358.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/rett-syndrome-discovery-could-lead-to-better-treatments/645364.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/reports/beyond-the-lab-stem-cell-research/645412.article 2026-04-01T08:46:23.070Z https://www.drugtargetreview.com/obstacles-and-innovations-of-macrocyclic-drug-development/645484.article 2026-03-12T14:56:12.350Z https://www.drugtargetreview.com/eurofins-launches-new-gmp-certification-for-supplements/645520.article 2026-03-12T12:11:21.773Z https://www.drugtargetreview.com/bio-rad-introduces-mixed-mode-resin-for-biomolecule-purification/645530.article 2026-03-12T15:18:11.707Z https://www.drugtargetreview.com/uvas-computer-models-target-antibiotics-to-combat-resistance/645535.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/new-study-shows-cgm-data-can-predict-diabetes-complications/645541.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/the-michael-j-fox-foundation-for-parkinsons-research-awards-grant-to-grifols-for-pioneering-study/645547.article 2026-03-12T14:28:43.587Z https://www.drugtargetreview.com/fdas-project-optimus-a-new-era-in-oncology-drug-dosing/645573.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/tle6-protein-deficiency-linked-to-male-infertility/645621.article 2026-03-12T12:49:49.387Z https://www.drugtargetreview.com/international-partnership-to-tackle-aggressive-adrenal-cancer/645635.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/first-patient-enrolled-in-fostamatinib-trial-for-sickle-cell-disease/645644.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/glox-therapeutics-secures-500k-to-develop-antibiotics-for-cystic-fibrosis/645652.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/coherus-announces-positive-phase-ii-results-for-liver-cancer-treatment/645657.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/new-study-explores-safer-antidepressants-for-pregnant-women/645710.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/cilta-cel-a-new-era-in-multiple-myeloma-treatment/645770.article 2026-03-31T09:53:28.153Z https://www.drugtargetreview.com/itm-11-boosts-survival-in-neuroendocrine-tumour-trial/645820.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/ai-designs-peptides-for-undruggable-diseases/645825.article 2026-03-12T15:34:25.173Z https://www.drugtargetreview.com/restoring-the-gut-ve303s-strategy-for-c-diff-relief/645828.article 2026-03-12T16:01:52.593Z https://www.drugtargetreview.com/azentas-bioarc-ultra-powers-uk-research/645832.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/the-immune-cells-that-fuel-food-allergies/645836.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/promising-alzheimers-drug-earns-fda-fast-track-designation/645883.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/new-cell-therapy-model-accelerates-cancer-treatment-development/645900.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/using-clinical-genomics-and-ai-in-drug-development-to-elevate-success/645906.article 2026-04-15T13:22:46.560Z https://www.drugtargetreview.com/new-study-links-type-2-diabetes-to-accelerated-cognitive-decline/645968.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/uc-davis-researchers-achieve-total-synthesis-of-ibogaine/646000.article 2026-03-12T16:12:57.900Z https://www.drugtargetreview.com/scientists-identify-key-protein-fuelling-autoimmune-attacks/646007.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/study-reveals-58-targets-for-heart-failure-drug-development/646017.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/ai-identifies-life-saving-treatment-for-rare-castlemans-disease/646022.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/antibiotic-resistance-linked-to-lack-of-nutrients-not-tough-bacteria/646027.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/scientific-workflow-for-hypothesis-testing-in-drug-discovery-part-3-of-3/646037.article 2026-04-15T13:50:52.737Z https://www.drugtargetreview.com/large-language-models-now-more-affordable-and-reliable-than-ever/646125.article 2026-03-11T17:12:45.653Z https://www.drugtargetreview.com/landmark-study-aims-to-detect-parkinsons-before-symptoms/646132.article 2026-03-12T14:28:43.587Z https://www.drugtargetreview.com/experts-explore-the-future-of-ipsc-based-cell-therapies/646139.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/capgeminis-ai-innovation-set-to-boost-bioeconomy/646180.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/study-identifies-new-genetic-targets-for-neuropsychiatric-diseases/646184.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/cn-bio-advances-hepatotoxicity-testing-to-reduce-drug-failures/646191.article 2026-03-12T16:01:52.593Z https://www.drugtargetreview.com/new-enzyme-discovery-could-boost-cancer-immunotherapy/646196.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/dna-repair-genes-drive-huntingtons-disease-ucla-study-finds/646202.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/new-therapy-shows-promise-in-strengthening-car-t-responses/646208.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/empowering-women-in-stem-championing-change-in-genetics/646215.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/the-future-of-cell-therapy-scaling-production-for-global-reach/646266.article 2026-03-12T15:52:23.637Z https://www.drugtargetreview.com/building-better-brain-models-for-parkinsons-disease-and-beyond/646406.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/foresight-consortium-secures-9-million-to-fast-track-drug-development/646460.article 2026-03-12T15:04:33.327Z https://www.drugtargetreview.com/new-predictive-model-identifies-synergistic-drug-pairings/646469.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/blood-pressure-drug-shows-promise-in-adhd-symptom-reduction/646480.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/new-gene-identified-for-treating-malignant-cardiac-arrhythmias/646486.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/ginger-based-compound-targets-inflammation-in-ibd/646492.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/hope-for-als-and-inflammatory-diseases-cellenkos-crane-technology-breakthrough/646747.article 2026-03-12T14:26:39.930Z https://www.drugtargetreview.com/new-insights-into-surfactant-spread-for-lung-drug-delivery/646756.article 2026-03-12T15:21:18.070Z https://www.drugtargetreview.com/refining-and-targeting-exatecan-with-adc-technology/646768.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/new-genetic-discovery-offers-hope-for-arthritis-drug-development/646860.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/leukaemia-cells-hit-hard-by-innovative-dual-drug-approach/646868.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/ai-designed-cdk12/13-inhibitors-target-resistant-cancers/646881.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/new-ai-algorithm-searches-10-sextillion-drug-candidates/646892.article 2026-03-12T11:44:18.617Z https://www.drugtargetreview.com/rare-diseases-big-advances-how-research-is-powering-a-new-era-of-treatments/646898.article 2026-03-12T14:40:00.053Z https://www.drugtargetreview.com/googles-ai-co-scientist-accelerates-drug-development/646914.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/obesity-care-gets-personalised-tailoring-therapies-with-phenomix/646977.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/the-future-of-mental-health-treatment-zelquistinels-role/646989.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/empowering-women-in-stem-navigating-cmc-regulatory-affairs/647000.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/shattering-the-glass-ceiling-empowering-women-and-girls-in-stem/647255.article 2026-03-12T11:35:58.207Z https://www.drugtargetreview.com/navigating-the-ai-revolution-a-roadmap-for-pharmas-future/647270.article 2026-04-15T13:26:05.200Z https://www.drugtargetreview.com/from-yale-to-healthcare-leader-dr-shika-pappoes-impact-on-kidney-care/647290.article 2026-03-12T08:29:41.283Z https://www.drugtargetreview.com/abbs-robotics-ecosystem-advancing-lab-efficiency-in-drug-discovery/647301.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/aws-and-elevatebio-join-forces-to-advance-gene-editing/647332.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/bacterial-jumping-genes-found-to-control-chromosome-ends/647340.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/scientists-turn-superbug-mrsa-into-treatable-infection/647354.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/why-dna-damage-response-deserves-renewed-focus-in-cancer-therapy/647355.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/first-ai-designed-drug-rentosertib-officially-named-by-usan/647365.article 2026-03-12T14:14:20.550Z https://www.drugtargetreview.com/diabetes-drug-found-to-protect-heart-during-cancer-treatment/647375.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/abelacimab-the-next-frontier-in-safer-anticoagulation-therapy-/647508.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/the-evolution-of-ai-in-drug-discovery-learning-from-historys-mistakes-part-1/647525.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/the-evolution-of-ai-in-drug-discovery-learning-from-historys-mistakes-part-2/647541.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/new-advances-in-hormone-replacement-therapy-set-to-transform-care/647556.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/reports/beyond-the-lab-artificial-intelligence/647571.article 2026-04-01T08:46:23.070Z https://www.drugtargetreview.com/nanoparticle-therapy-shows-potential-to-prevent-spread-of-pancreatic-cancer-to-liver/647573.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/fairjourney-biologics-acquires-charles-rivers-south-san-francisco-facility/647610.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/beckman-coulter-life-sciences-and-rarity-bioscience-partner-to-advance-oncology-research/647620.article 2026-03-12T14:06:00.103Z https://www.drugtargetreview.com/scientists-discover-key-to-long-covid-lung-damage-and-potential-treatment/647696.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/gene-silencing-a-step-forward-for-rare-disease-therapy/647722.article 2026-04-20T23:39:07.553Z https://www.drugtargetreview.com/cespiace-new-peptide-drug-blocks-covid-19-variants/647812.article 2026-03-12T15:34:25.173Z https://www.drugtargetreview.com/new-research-offers-hope-for-high-grade-glioma-treatment/647827.article 2026-03-12T15:50:28.580Z https://www.drugtargetreview.com/novel-radioactive-drug-targets-aggressive-metastatic-melanoma/648009.article 2026-03-12T16:07:20.587Z https://www.drugtargetreview.com/tract-bio-identifies-drug-targets-for-oesophageal-cancer/648070.article 2026-03-12T09:19:21.710Z https://www.drugtargetreview.com/drug-olx-07010-shows-promise-in-treating-tau-diseases/648090.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/new-approach-targets-vhr-enzyme-for-sepsis-treatment/648104.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/study-aims-to-stop-alzheimers-with-stem-cell-infusions/648110.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/study-identifies-crucial-gene-behind-metabolic-liver-disease/648155.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/b-cell-discovery-could-supercharge-future-vaccine-development/648213.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/next-gen-biotech-rbios-approach-to-affordable-insulin-solutions/648236.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/the-rising-impact-of-biomarkers-in-early-clinical-development/648249.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/advancements-in-hit-identification-for-membrane-protein-drug-discovery/648267.article 2026-03-12T14:50:38.220Z https://www.drugtargetreview.com/new-melanoma-therapy-prevents-brain-metastasis-in-preclinical-studies/648591.article 2026-03-12T16:07:20.587Z https://www.drugtargetreview.com/early-evidence-and-emerging-trends-how-ai-is-shaping-drug-discovery-and-clinical-development/648593.article 2026-04-15T13:25:52.080Z https://www.drugtargetreview.com/new-study-reveals-how-bacteria-vaccinate-with-viral-dna/648604.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/gyldens-gold-platform-trains-t-cells-to-kill-viruses/648605.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/alzheimers-treatment-targets-root-causes-not-just-symptoms/648640.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/new-hydrogel-tech-shows-promise-for-treating-post-traumatic-osteoarthritis/648843.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/stem-cell-study-uncovers-shared-genes-for-hearing-and-vision-repair/648853.article 2026-03-12T15:51:18.717Z https://www.drugtargetreview.com/identifying-a-new-target-for-metabolic-liver-disease-treatment/648866.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/pspc1-knockout-slows-aml-in-preclinical-models/648880.article 2026-03-12T15:16:39.993Z https://www.drugtargetreview.com/spirulinas-role-in-shaping-the-future-of-preventative-biologics/648909.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/advanced-drug-development-for-neurodegenerative-diseases-with--synuclein/648949.article 2026-04-20T23:31:03.733Z https://www.drugtargetreview.com/lb-102-redefining-schizophrenia-treatment-in-drug-discovery/648966.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/takara-bio-usa-inc/649070.article 2026-03-05T11:58:57.630Z https://www.drugtargetreview.com/poster-lentiviral-gene-delivery-workflow/649075.article 2026-03-19T10:32:43.847Z https://www.drugtargetreview.com/new-leadership-at-elrig-aims-to-expand-collaboration-across-drug-discovery/649244.article 2026-03-12T12:11:21.773Z https://www.drugtargetreview.com/key-pkd-findings-could-accelerate-development-of-new-treatments/649259.article 2026-03-12T16:02:37.187Z https://www.drugtargetreview.com/reprogramming-gut-cells-to-treat-short-bowel-syndrome/649265.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/bacteria-boosted-nanoparticles-offer-a-triple-threat-against-cancer/649309.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/promising-psoriasis-treatment-reduces-symptoms-without-steroids/649360.article 2026-03-12T15:34:25.173Z https://www.drugtargetreview.com/ai-powered-imaging-for-faster-lung-disease-treatment/649376.article 2026-03-12T13:05:01.160Z https://www.drugtargetreview.com/ai-in-drug-discovery-faster-smarter-better/649384.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/building-the-requisite-clinical-development-infrastructure-for-medical-innovation-to-thrive/649395.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/optimising-analytical-strategies-for-adc-development/649405.article 2026-03-12T14:23:56.053Z https://www.drugtargetreview.com/next-gen-adcs-tubulis-sets-new-standard-in-cancer-treatment/649412.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/cracking-the-code-to-scalable-cell-and-gene-therapy/649501.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/driving-diversity-and-leadership-in-the-biotech-industry/649510.article 2026-03-12T14:09:43.590Z https://www.drugtargetreview.com/new-fixed-duration-therapy-could-reshape-cll-care/649517.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/pioneering-cellular-therapies-for-age-related-diseases/649569.article 2026-03-12T16:01:52.593Z https://www.drugtargetreview.com/outsmarting-cancer-by-exploiting-dna-repair-flaws/649597.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/fibril-fuzzy-coats-boost-parkinsons-protein-spread/649641.article 2026-03-12T15:12:22.770Z https://www.drugtargetreview.com/advanced-test-predicts-alk-inhibitor-success-in-lung-cancer/649652.article 2026-03-12T14:30:59.547Z https://www.drugtargetreview.com/bone-repair-breakthrough-why-men-and-women-heal-differently/649662.article 2026-03-12T14:30:59.547Z https://www.drugtargetreview.com/new-study-identifies-key-immune-cells-that-prevent-food-allergies/649685.article 2026-03-12T15:33:45.497Z https://www.drugtargetreview.com/using-knowledge-graphs-in-drug-discovery-part-1-how-they-link-to-large-language-models/649734.article 2026-04-15T13:43:45.730Z https://www.drugtargetreview.com/using-knowledge-graphs-in-drug-discovery-part-2-how-theyre-shaping-scientific-progress/649741.article 2026-04-15T14:47:53.407Z https://www.drugtargetreview.com/synthetic-promoters-enhance-gene-therapy-precision/649802.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/ai-at-the-forefront-of-age-related-disease-treatment/649807.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/polb-001-tackling-cytokine-storms-before-they-start/649921.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/reports/beyond-the-lab-clinical-trials/649929.article 2026-04-01T11:47:25.607Z https://www.drugtargetreview.com/lab-grown-liver-breakthrough-could-speed-up-drug-development/649933.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/guide-create-dna-template-for-in-vitro-mrna-synthesis/649940.article 2026-03-31T12:40:10.950Z https://www.drugtargetreview.com/new-drug-combination-shows-potential-to-treat-enteroviruses/649982.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/building-better-drugs-how-3d-models-are-shaping-pre-clinical-development/649997.article 2026-03-12T14:30:59.547Z https://www.drugtargetreview.com/new-liver-organoids-research-brings-hope-for-drug-development/650001.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/targeting-zombie-cells-a-new-treatment-for-chronic-back-pain/650015.article 2026-03-12T15:24:42.493Z https://www.drugtargetreview.com/repurposed-anti-inflammatory-drug-may-help-treat-alcohol-use-disorders/650023.article 2026-03-12T15:53:02.083Z https://www.drugtargetreview.com/targeting-inflammation-to-treat-atherosclerosis-and-mash/650247.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/blocking-nitrosylation-boosts-treatment-for-nras-melanoma/650294.article 2026-03-12T15:07:08.350Z https://www.drugtargetreview.com/new-dual-targeting-strategy-shows-promise-in-treating-pancreatic-cancer/650305.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/transforming-biotherapeutics-delivery-for-local-communities/650331.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/scientists-develop-immunotherapy-to-disarm-fat-fuelled-tumours/650339.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/new-plasma-therapy-fights-aggressive-soft-tissue-cancer/650342.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/how-ai-and-llms-are-transforming-drug-discovery-part-1/650399.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/how-ai-and-llms-are-transforming-drug-discovery-part-2/650415.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/allele-selective-gene-editing-a-breakthrough-in-huntingtons-disease-treatment/650421.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/eli-lilly-backs-creyons-quantum-chemistry-platform-in-1b-rna-drug-deal/650535.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/aacr-2025-translating-research-into-real-world-impact/650554.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/new-enzyme-tech-offers-hope-for-mitochondrial-disease-treatment/650573.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/tackling-complex-manufacturing-challenges-in-modern-drug-development/650581.article 2026-03-12T15:01:01.037Z https://www.drugtargetreview.com/from-siloed-data-to-breakthroughs-multimodal-ai-in-drug-discovery/650597.article 2026-04-15T13:25:38.103Z https://www.drugtargetreview.com/high-throughput-nav19-assay-to-advance-pain-therapies/650644.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/targeting-glp-1-in-the-brain-could-transform-obesity-care/650659.article 2026-04-17T16:08:35.280Z https://www.drugtargetreview.com/app-note-high-throughput-single-cell-genome-profiling/650667.article 2026-03-12T14:03:03.100Z https://www.drugtargetreview.com/new-trna-tech-aims-to-rewrite-rare-disease-treatment/650841.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/enedra-secures-funding-to-advance-ai-driven-cancer-platform/651243.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/new-data-visugromab-targets-adc-resistance-mechanism/651277.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/new-ovaroid-model-research-offers-hope-for-reproductive-disorders/651744.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/k-navigator-an-ai-co-pilot-transforming-biomedical-research/651909.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/targeting-pla2g15-to-treat-neurometabolic-disorders/651934.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/elrigs-drug-discovery-2025-announces-event-speakers/651956.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/transforming-cancer-care-through-clinical-excellence/651968.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/new-investigational-therapy-shows-promise-for-treating-skeletal-disorders/651970.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/targeting-the-clock-new-drug-disrupts-glioblastoma-stem-cells/652015.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/nasal-spray-gene-therapy-shows-potential-to-treat-lung-diseases/652558.article 2026-03-12T16:17:50.147Z https://www.drugtargetreview.com/new-biobank-offers-hope-for-sufferers-of-dry-mouth/652570.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/strategic-planning-in-adc-development-insights-from-lonza/652617.article 2026-03-12T14:45:55.883Z https://www.drugtargetreview.com/automated-red-blood-cell-exchange-bridging-treatment-gaps-in-sickle-cell-disease-care/652622.article 2026-03-12T14:58:32.143Z https://www.drugtargetreview.com/vascularised-stem-cell-organoids-advance-diabetes-therapy/652664.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/how-gpcr-targeting-therapies-are-advancing-the-fight-against-inflammatory-disease/652694.article 2026-03-12T16:01:52.593Z https://www.drugtargetreview.com/new-ucd-centre-targets-the-biggest-bottleneck-in-rare-research/652764.article 2026-03-12T14:40:00.053Z https://www.drugtargetreview.com/why-atp-signalling-might-change-melanoma-for-good/652790.article 2026-03-12T15:07:08.350Z https://www.drugtargetreview.com/what-slas-2025-really-told-us-about-drug-discovery/652934.article 2026-03-31T09:54:34.600Z https://www.drugtargetreview.com/astrocyte-protein-rtp801-linked-to-alzheimers-cognitive-decline/653184.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/herpes-virus-protein-boosts-t-cell-power-against-cancer/653193.article 2026-03-12T14:26:39.930Z https://www.drugtargetreview.com/chemical-hack-turns-platelets-into-drug-couriers/653199.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/engineering-realistic-blood-vessels-to-fight-vascular-disease/653205.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/experimental-peptide-targets-glioblastomas-most-resilient-cells/653214.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/scientists-create-advanced-3d-liver-model-mimicking-real-tissue/653243.article 2026-03-12T16:01:52.593Z https://www.drugtargetreview.com/ai-targets-protein-linked-to-most-human-cancers/653248.article 2026-03-12T14:56:12.350Z https://www.drugtargetreview.com/study-identifies-safer-target-for-dopamine-linked-disorders/653262.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/bcg-alters-bone-marrow-to-strengthen-anti-cancer-response/653268.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/next-generation-drug-design-how-generative-ai-can-tackle-undruggable-targets/653308.article 2026-03-12T15:10:16.897Z https://www.drugtargetreview.com/solving-the-disconnect-between-lab-and-data-scientists-part-1/653778.article 2026-04-15T13:33:56.333Z https://www.drugtargetreview.com/solving-the-disconnect-between-lab-and-data-scientists-part-2/653786.article 2026-04-15T13:35:12.487Z https://www.drugtargetreview.com/why-radiopharmaceuticals-are-gaining-ground-in-the-fight-against-cancer/654007.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/the-next-phase-of-the-multiomics-evolution-powered-by-ai/654074.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/shifting-the-adc-focus-from-antibody-to-payload/654115.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/statins-repurposed-for-sepsis-show-life-saving-potential/654725.article 2026-03-12T14:29:49.063Z https://www.drugtargetreview.com/inside-the-immune-handbook-set-to-disrupt-fibrosis-research/654736.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/ai-just-made-protein-design-smarter-and-faster/654745.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/how-one-carbon-atom-is-changing-drug-development/654768.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/engineered-dna-aptamers-outsmart-viral-infection-pathways/654779.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/a-global-push-for-better-animal-welfare-in-research/655181.article 2026-03-12T12:54:52.520Z https://www.drugtargetreview.com/a-spatial-approach-to-understanding-drug-dynamics-using-mass-spectrometry-imaging/655211.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/machine-learning-and-ai-in-enhancing-image-analysis-of-3d-samples/655236.article 2026-03-12T14:29:49.063Z https://www.drugtargetreview.com/sb000-a-safer-path-to-anti-aging-therapies/655239.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/translating-promising-drug-candidates-from-preclinical-screening-to-clinical-trials/655253.article 2026-03-12T13:01:17.453Z https://www.drugtargetreview.com/plasmids-tackling-supply-chain-and-manufacturing-challenges/655265.article 2026-04-07T13:34:10.170Z https://www.drugtargetreview.com/stanford-grows-vascularised-mini-organs/655379.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/reelin-identified-as-key-marker-of-cocaine-activated-brain-cells/655523.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/organoids-take-on-esccs-toughest-tumours/655538.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/3d-model-reveals-hidden-drivers-of-smell-regeneration/655556.article 2026-03-13T12:10:46.787Z https://www.drugtargetreview.com/dual-action-therapy-clears-mdr-bacteria-in-preclinical-models/655575.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/new-therapy-for-incurable-brain-disease-heads-to-clinical-trials/656129.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/scientists-discover-enzymes-that-redefine-glycan-pathways/656151.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/why-playing-it-safe-is-slowing-down-drug-discovery/656162.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/new-polymer-boosts-mrna-vaccine-safety/656169.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/new-nanoparticle-enhances-cancer-drug-penetration/656187.article 2026-03-12T15:03:13.317Z https://www.drugtargetreview.com/pain-relief-without-the-risk-why-srp-001-could-change-everything/656196.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/rethinking-antibody-discovery-in-the-age-of-automation/656235.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/turning-ai-into-a-biological-design-engine/656250.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/ai-platform-detects-new-drug-targets-in-minutes/656597.article 2026-03-13T12:10:46.787Z https://www.drugtargetreview.com/new-partnership-targets-cns-symptoms-in-ultra-rare-diseases/656613.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/scientists-grow-3d-brain-that-mimics-the-real-thing/656628.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/experimental-drug-targets-gene-driving-severe-seizures-in-children/656648.article 2026-03-13T12:08:21.110Z https://www.drugtargetreview.com/delete-to-recruit-new-gene-editing-method-targets-sickle-cell/656657.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/new-discovery-shows-how-viral-vectors-release-genes-in-therapy/656666.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/250k-grant-fuels-development-of-new-type-1-diabetes-therapy/656999.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/new-drug-combo-targets-colorectal-cancer-mutation/657009.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/smart-automation-for-every-lab-not-just-big-pharma/657011.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/why-parp-inhibitors-fail-key-role-of-the-cst-complex-in-brca1-deficient-cancers/657016.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/protein-folding-milestone-achieved-with-quantum-tech/657218.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/inside-aacr-darpins-take-aim-at-hard-to-treat-tumours/657516.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/the-biotech-mapping-thousands-of-hidden-therapeutic-clues/657523.article 2026-03-12T14:06:00.103Z https://www.drugtargetreview.com/programming-immunity-from-within-in-body-generation-of-car-t-cells/657547.article 2026-03-13T12:13:36.773Z https://www.drugtargetreview.com/future-proofing-drug-development-with-genai/657556.article 2026-03-12T14:30:59.547Z https://www.drugtargetreview.com/bird-flu-is-changing-ai-might-help-us-keep-up/657566.article 2026-03-12T15:03:13.317Z https://www.drugtargetreview.com/key-to-potential-new-alzheimers-drugs-found-in-sugar-enzyme/657895.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/how-bowel-cancer-beats-treatment-and-how-ai-can-stop-it/657915.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/disabling-the-setd1b-enzyme-halts-leukaemia-cell-growth/657925.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/fixing-failed-drugs-ai-solutions-for-toxicity-in-drug-discovery-part-1/657929.article 2026-04-15T13:35:32.667Z https://www.drugtargetreview.com/fixing-failed-drugs-ai-solutions-for-toxicity-in-drug-discovery-part-2/657936.article 2026-04-15T13:33:00.560Z https://www.drugtargetreview.com/fixing-failed-drugs-ai-solutions-for-toxicity-in-drug-discovery-part-3/657954.article 2026-04-15T13:33:18.523Z https://www.drugtargetreview.com/meet-the-hemifusome-a-new-organelle-with-big-impact/657964.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/sod1-protein-found-to-trigger-treatable-parkinsons-progression/657968.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/liver-organoids-grow-functional-blood-vessels-in-lab-breakthrough/657978.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/fgf19-hormone-could-be-the-key-to-new-obesity-treatments/657983.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/time-for-change-non-human-primates-in-drug-research/658064.article 2026-04-07T11:24:11.757Z https://www.drugtargetreview.com/the-future-of-cns-drug-development-signs-of-real-progress/658079.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/new-data-backs-myo4-for-obesity-treatment/658097.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/the-ai-model-that-is-changing-clinical-trial-design/658128.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/transform-your-drug-discovery-pipeline-with-3d-cellular-models/658347.article 2026-03-31T12:39:50.643Z https://www.drugtargetreview.com/how-dual-targeting-adcs-aim-to-tackle-resistance/658371.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/ngs-is-evolving-collaboration-and-tech-lead-the-way/658383.article 2026-03-12T15:01:01.037Z https://www.drugtargetreview.com/fixing-drug-discoverys-most-persistent-problem-with-ai/658391.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/virtual-cell-model-rankings-just-got-a-major-upgrade/658515.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/small-molecule-therapy-improves-islet-transplant-success-in-diabetes/658545.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/designing-antibodies-to-think-before-they-bind/658549.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/from-lab-to-clinic-the-rise-of-radio-darpins-in-oncology/658554.article 2026-03-12T15:34:25.173Z https://www.drugtargetreview.com/antibodies-come-full-circle-biopharma-back-at-the-bench/658555.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/qtx153-reverses-rett-symptoms-and-crosses-key-drug-delivery-barrier/658918.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/leukaemia-on-a-chip-mimics-bone-marrow-for-better-car-t-testing/658936.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/linc01235-identified-as-driver-of-aggressive-breast-cancer/658961.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/outsmarting-immune-suppression-through-gpcr-innovation/658974.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/new-mouse-model-mimics-rare-grin2d-disorder/659097.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/slowing-intracellular-transport-boosts-potential-for-rna-therapies/659108.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/rapid-cell-reprogramming-creates-lung-like-cells-to-combat-copd/659116.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/can-skin-heal-like-our-mouth-a-new-study-says-it-might/659128.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/optimising-t-cell-expansion-to-improve-early-stage-cell-therapy/659304.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/what-single-cells-are-revealing-about-brain-disorders/659606.article 2026-03-12T14:29:49.063Z https://www.drugtargetreview.com/gene-therapy-boosts-car-t-power-against-glioblastoma/659639.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/mitochondria-melanomas-hidden-vulnerability/659655.article 2026-03-12T15:07:08.350Z https://www.drugtargetreview.com/microglia-discovery-offers-clues-to-alzheimers-progression/667638.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/bile-acid-enhanced-liver-organoids-set-to-improve-liver-disease-treatment/667648.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/dual-car-t-cell-therapy-targets-t-all-with-precision/667721.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/targeting-mapk-and-pi3k/mtor-pathways-halts-ovarian-cancer-growth/667726.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/a-gentle-squeeze-scientists-use-physical-force-to-transform-stem-cells-into-bone/667841.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/the-unexpected-role-of-fda-approved-drugs-in-making-nanoparticles-safer/667851.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/new-drug-gai-17-reduces-stroke-induced-brain-cell-death/668144.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/new-class-of-chiral-molecules-offers-strong-stability-for-drug-development/668148.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/microglia-replacement-halts-alsp-progression-in-landmark-trials/668157.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/new-standards-for-brain-organoids-aim-to-boost-drug-discovery/668544.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/how-a-prl3-targeting-cancer-drug-could-help-millions-see-again/668556.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/new-weekly-injection-could-transform-parkinsons-disease-treatment/668639.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/15m-backed-tech-targets-tumour-complexity/668660.article 2026-03-13T12:10:46.787Z https://www.drugtargetreview.com/discovery-of-hidden-survival-mechanism-in-mrsa-points-to-new-drug-targets/668808.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/autoimmune-breakthrough-egr-1-regulates-treg-cells-in-diseases-like-ms/668924.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/new-ai-model-protsi-identifies-aggressive-tumours-using-protein-markers/668935.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/new-3d-bioprinted-lung-tissue-could-transform-respiratory-research/668943.article 2026-03-12T15:50:52.830Z https://www.drugtargetreview.com/smart-nanogels-help-car-t-cells-penetrate-tumours/669102.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/new-sticky-material-mimics-gecko-feet-to-fight-tumours/669114.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/pioneering-nipah-vaccine-for-pigs-aims-to-protect-humans-too/669388.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/deep-sea-sugar-eps39-sparks-immune-attack-on-tumours/669528.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/elrig-announces-keynote-speakers-for-drug-discovery-2025-in-liverpool/669537.article 2026-03-11T15:44:25.547Z https://www.drugtargetreview.com/reports/beyond-the-lab-biomarkers-powering-tomorrows-therapies/669538.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/tracing-acly-from-cardiovascular-target-to-liver-therapy-lead/669597.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/why-smarter-financial-planning-could-be-key-to-clinical-trial-success/669619.article 2026-03-12T13:01:17.453Z https://www.drugtargetreview.com/managing-cgt-trials-the-role-of-irt-from-discovery-to-clinical-development/669630.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/scientists-discover-neuron-like-communication-in-gut-cells/669813.article 2026-03-12T16:01:52.593Z https://www.drugtargetreview.com/how-ftsz-and-zapa-proteins-drive-bacterial-cell-division/669819.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/new-drug-combo-targets-prmt5-to-fight-deadly-cancers/669900.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/cdk4/6-and-parp-combo-improves-prostate-cancer-treatment/669908.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/from-injections-to-pills-oral-peptides-set-to-transform-drug-development/669951.article 2026-04-07T14:51:53.303Z https://www.drugtargetreview.com/new-research-shows-squeezing-cancer-cells-helps-them-survive/670031.article 2026-03-12T12:39:56.787Z https://www.drugtargetreview.com/lupus-reimagined-targeting-the-cause-not-just-the-symptoms/670045.article 2026-04-07T14:49:10.277Z https://www.drugtargetreview.com/new-stroke-drug-reduces-brain-damage-by-60-percent-in-preclinical-study/670409.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/mast-cells-new-target-for-preventing-meningitis-and-brain-disease/670416.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/intersectin-protein-discovery-may-help-treat-cognitive-disorders/670541.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/covid-19-and-flu-could-awaken-hidden-breast-cancer-cells/670546.article 2026-03-12T15:13:50.943Z https://www.drugtargetreview.com/vitamin-b1--glucose-a-new-combination-approach-to-tackling-sepsis/670688.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/new-lipid-nanoparticle-boosts-mrna-delivery-fivefold-in-cancer-study/670702.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/scientists-discover-how-5-ht1a-receptor-shapes-brain-signalling/670730.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/whole-brain-organoid-offers-breakthrough-in-neurological-research/670817.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/fuelling-immunity-glucose-helps-t-cells-fight-cancer-better/670853.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/ai-driven-alzheimers-therapies-show-promise-in-early-studies/670970.article 2026-03-12T15:34:25.173Z https://www.drugtargetreview.com/why-most-t-cell-engagers-fail-and-how-to-fix-it/670975.article 2026-04-07T14:58:17.757Z https://www.drugtargetreview.com/next-gen-malaria-vaccine-created-using-mapped-parasite-protein/671020.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/challenges-in-developing-robust-potency-assays-for-adcs/671021.article 2026-04-07T14:47:21.287Z https://www.drugtargetreview.com/what-if-drug-discovery-took-months-not-decades/671042.article 2026-04-07T14:45:22.150Z https://www.drugtargetreview.com/turning-up-the-heat-simple-temperature-change-makes-versatile-vaccine-nanoparticles/671290.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/how-ai-is-quietly-changing-drug-manufacturability/671304.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/new-patent-for-traumatic-brain-injury-drug-announced/671500.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/targeted-microglia-transplant-reverses-signs-of-rare-brain-disorder/671542.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/lithium-deficiency-identified-as-key-alzheimers-trigger/671585.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/kidney-tumour-organoids-offer-new-drug-testing-platform/671879.article 2026-03-12T16:01:52.593Z https://www.drugtargetreview.com/new-pcai-compound-targets-aromatase-inhibitor-resistant-breast-cancer/671916.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/how-to-select-the-optimal-bispecific-antibody-format-for-therapeutic-success/671936.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/how-to-select-the-optimal-bispecific-antibody-format-for-therapeutic-success/671940.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/ecdna-discovery-targets-zombie-cells-in-childhood-cancers/672206.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/beyond-the-hype-a-veterans-honest-assessment-of-ai-in-drug-discovery-part-1/672250.article 2026-04-07T13:45:04.067Z https://www.drugtargetreview.com/evenamide-targets-multiple-symptoms-in-schizophrenia-models/672312.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/scientists-develop-3d-printed-dermis-for-faster-burn-recovery/672514.article 2026-03-12T15:12:02.060Z https://www.drugtargetreview.com/fda-approved-asthma-drug-may-protect-against-food-allergy-reactions/672534.article 2026-03-12T15:33:45.497Z https://www.drugtargetreview.com/new-crispr-breakthrough-could-transform-sickle-cell-treatment/673354.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/making-sense-of-ai-bias-trust-and-transparency-in-pharma-randd/673358.article 2026-04-15T13:30:31.827Z https://www.drugtargetreview.com/researchers-identify-early-intervention-target-for-cerebral-palsy-dystonia/673603.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/striosomes-may-hold-the-key-to-better-treatments-for-mental-disorders/673650.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/planaria-flatworms-provide-new-way-to-study-schizophrenia-drugs/673943.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/consumables-engineered-for-speed-and-reproducibility-in-drug-discovery/673967.article 2026-03-12T14:42:34.353Z https://www.drugtargetreview.com/kidney-organoids-reveal-hidden-toxicities-in-aav-gene-therapy/673999.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/inside-the-alzheimers-study-backing-stem-cells-not-drugs/674013.article 2026-03-12T14:29:49.063Z https://www.drugtargetreview.com/new-therapy-targets-triglycerides-to-prevent-aneurysms/674026.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/inside-the-search-and-develop-model-tackling-1000-untreated-skin-diseases/674027.article 2026-04-07T14:44:14.570Z https://www.drugtargetreview.com/from-graphene-to-grey-matter-tech-that-supercharges-brain-organoids/674134.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/why-scientists-are-targeting-the-gut-to-treat-peanut-allergy/674147.article 2026-04-07T12:56:21.030Z https://www.drugtargetreview.com/beyond-the-hype-a-veterans-honest-assessment-of-ai-in-drug-discovery-part-2/674158.article 2026-03-12T14:40:00.053Z https://www.drugtargetreview.com/repurposed-epilepsy-drugs-show-potential-for-new-autism-therapies/674268.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/chikungunyas-2025-surge-sparks-urgent-research-response/674282.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/cholesterol-drug-restores-brain-barrier-function-in-22q112-syndrome-models/674319.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/new-zika-vaccine-prevents-infection-and-organ-damage/674324.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/new-imaging-technique-tracks-obesity-drug-tirzepatide-in-cells/674764.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/new-m13-virus-method-could-change-future-genetic-treatments/674772.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/animal-free-drug-discovery-is-closer-with-qsp/674788.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/lab-of-the-future-four-technologies-to-watch/674818.article 2026-04-07T13:31:54.797Z https://www.drugtargetreview.com/gene-therapies-that-listen-and-respond-the-power-of-rna-regulation/674840.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/advancing-antiviral-therapeutics-for-immunocompromised-populations/674855.article 2026-04-07T13:15:45.500Z https://www.drugtargetreview.com/dna-organiser-stag3-could-advance-infertility-and-cancer-research/674961.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/hijacking-leydig-cells-how-covid-19-lowers-testosterone/674987.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/beyond-the-hype-a-veterans-honest-assessment-of-ai-in-drug-discovery-part-3/675010.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/scientists-chart-ovarian-reserve-to-help-advance-new-infertility-treatments/675142.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/new-ai-method-maps-how-tuberculosis-drugs-destroy-bacteria/675159.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/non-invasive-method-images-brain-development-in-juvenile-mice/675183.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/chronic-neuron-overactivation-drives-parkinsons-cell-death/675200.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/key-newborn-liver-cells-could-boost-paediatric-gene-therapy/675345.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/feline-cancer-breakthrough-could-help-treat-human-tumours/675352.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/ai-meets-human-tissue-to-fast-track-precision-medicine-development/675362.article 2026-04-07T13:20:54.930Z https://www.drugtargetreview.com/three-powerful-antibodies-discovered-with-potential-to-treat-mpox/675984.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/new-nanostructure-makes-crispr-edits-safer-and-three-times-faster/676004.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/ai-designs-new-antibiotics-to-take-on-drug-resistant-superbugs/676174.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/breakthrough-glioblastoma-research-wins-400k-charity-funding/676439.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/scientists-spotlight-lung-disease-as-fast-track-model-for-ageing-drugs/676449.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/better-assays-the-key-step-in-moving-drugs-from-lab-to-clinic/676778.article 2026-04-07T13:03:33.033Z https://www.drugtargetreview.com/car-ts-biggest-hurdle-solving-the-toxicity-problem/676787.article 2026-04-07T13:31:03.907Z https://www.drugtargetreview.com/targeting-gene-regulation-may-hold-key-to-future-alzheimers-therapies/676930.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/overcoming-barriers-to-oncology-combination-therapies-in-the-uk-and-eu/677012.article 2026-04-07T12:28:34.367Z https://www.drugtargetreview.com/inside-zasocitinib-a-new-model-for-tyk2-inhibition-in-immune-mediated-diseases/677029.article 2026-04-07T12:22:22.660Z https://www.drugtargetreview.com/blocking-gpnmb-may-halt-triple-negative-breast-cancer-progression/677040.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/pdx-models-are-back-and-theyre-exposing-what-cell-lines-missed/677056.article 2026-04-07T13:01:56.337Z https://www.drugtargetreview.com/the-science-behind-the-systematic-discovery-of-molecular-glues/677071.article 2026-03-12T14:56:12.350Z https://www.drugtargetreview.com/from-data-to-therapy-emerging-tech-driving-cancer-drug-discovery/677075.article 2026-04-07T12:17:38.147Z https://www.drugtargetreview.com/new-smart-tool-maps-rna-modifications-to-tackle-cancer-and-infections/677122.article 2026-03-12T14:29:49.063Z https://www.drugtargetreview.com/eurofins-assurance-gains-iso/iec-170652012-gmp-accreditation/677135.article 2026-03-12T12:11:21.773Z https://www.drugtargetreview.com/single-cell-technique-tracks-boron-in-live-tumour-cells/677193.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/mass-spectrometry-workflows-powering-the-future-of-biologics/677313.article 2026-04-07T11:39:03.203Z https://www.drugtargetreview.com/fast-tracking-advanced-therapies-without-compromising-regulatory-success/677327.article 2026-03-12T14:29:49.063Z https://www.drugtargetreview.com/tumour-stress-drives-t-cell-exhaustion-antioxidants-may-reverse-it/677336.article 2026-03-12T14:26:39.930Z https://www.drugtargetreview.com/how-circulating-tumour-cell-organoids-are-transforming-oncology/677694.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/soils-hidden-bacteria-could-hold-future-antibiotic-breakthroughs/677701.article 2026-03-13T12:10:46.787Z https://www.drugtargetreview.com/rare-disease-drugs-get-boost-from-new-nice-guidelines/677768.article 2026-03-12T14:40:00.053Z https://www.drugtargetreview.com/mapping-lung-disease-new-atlas-to-accelerate-drug-discovery/677773.article 2026-03-13T12:10:46.787Z https://www.drugtargetreview.com/new-stem-cell-approach-could-repair-stroke-damaged-brains/677869.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/new-therapies-boost-deep-brain-stimulation-accuracy-in-epilepsy/677882.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/melanoma-research-targeted-drug-duo-reactivates-immune-response/677956.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/prorna3d-single-new-ai-for-drug-discovery-and-disease-research/677965.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/anti-linker-antibodies-a-universal-key-for-car-t-detection/677974.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/new-obesity-drug-res-010-targets-metabolism-to-prevent-weight-regain/677995.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/registration-for-elrigs-drug-discovery-2025-closes-on-30-september/678031.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/novltex-new-antibiotic-targets-antimicrobial-resistance/678051.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/advancing-gene-editing-the-role-of-lipid-nanoparticles-in-crispr-delivery/678056.article 2026-04-07T11:13:59.347Z https://www.drugtargetreview.com/lab-grown-kidneys-show-real-function-in-new-stem-cell-study/678183.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/nanoparticles-turn-vinegar-into-powerful-antimicrobial-treatment/678257.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/eye-movements-as-objective-biomarkers-accelerating-cns-drug-development/678266.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/gut-probiotics-could-offer-relief-for-sickle-cell-disease-pain/678279.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/fibroblast-mapping-reveals-potential-universal-drug-targets/678390.article 2026-03-13T12:10:46.787Z https://www.drugtargetreview.com/marine-sponges-could-hold-the-key-to-new-leishmaniasis-treatments/678454.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/the-road-to-safer-painkillers-the-role-of-the-ep2-receptor/678469.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/glioblastoma-treatment-boosted-by-new-drug-combination-strategy/678497.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/oral-bacteria-in-gut-could-play-role-in-parkinsons-disease-development/678505.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/beyond-templates-advancing-protein-protein-interaction-structure-prediction-with-ai/678511.article 2026-04-07T11:30:02.360Z https://www.drugtargetreview.com/an-ethical-shift-in-nhp-research-ipsc-derived-cardiomyocytes-for-safer-pharmacology/678522.article 2026-04-07T11:18:26.310Z https://www.drugtargetreview.com/protecting-bones-from-cancer-damage-targeting-the-upr-pathway/678552.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/accessible-automation-may-change-your-day-to-day-sooner-than-you-think/678553.article 2026-04-02T14:49:20.870Z https://www.drugtargetreview.com/comfb-protein-discovery-could-help-fight-antibiotic-resistance/678674.article 2026-03-12T15:19:41.130Z https://www.drugtargetreview.com/severe-flu-during-pregnancy-compromises-placental-and-brain-barriers/678691.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/tiny-models-powerful-insights-how-organoids-are-driving-precision-oncology/678702.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/senolytic-drug-combo-boosts-cancer-immunotherapy-and-reduces-side-effects/678805.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/hibernator-liver-organoids-reveal-strategy-to-improve-transplant-survival/678818.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/hypoxia-and-eudal-the-hidden-drivers-of-oral-cancer-survival/678839.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/new-car-t-therapy-targets-solid-tumours-safely-and-effectively/678882.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/cloneseq-sv-new-blood-test-tracks-ovarian-cancer-recurrence/678910.article 2026-03-13T12:10:46.787Z https://www.drugtargetreview.com/fighting-ms-progression-why-gpr17-is-the-target-to-watch/678918.article 2026-04-07T11:32:09.577Z https://www.drugtargetreview.com/kidney-organoids-show-apol1-genes-role-in-chronic-kidney-disease/678992.article 2026-03-12T16:01:52.593Z https://www.drugtargetreview.com/blocking-slamf6-enables-t-cells-to-kill-leukaemia-cells/679003.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/scientists-track-amyloid-plaques-in-living-mice-for-first-time/679009.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/streamlining-biomanufacturing-of-personalised-cancer-immunotherapies-with-synthetic-dna/679164.article 2026-03-12T14:30:59.547Z https://www.drugtargetreview.com/targeting-ezh2-may-prevent-triple-negative-breast-cancer-spread/679180.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/pemafibrate-and-telmisartan-combo-may-reverse-fatty-liver/679185.article 2026-03-12T16:01:52.593Z https://www.drugtargetreview.com/new-nanotherapy-clears-amyloid--reversing-alzheimers-in-mice/679235.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/4basebio-plc/679236.article 2026-03-05T11:58:58.133Z https://www.drugtargetreview.com/ddhd2-enables-neurons-to-synthesise-and-burn-fat-for-energy/679278.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/c-kit-helps-sweet-cells-survive-and-regenerate-taste/679292.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/chemistry-aware-ai-offers-new-routes-in-small-molecule-design/679379.article 2026-04-07T10:47:22.573Z https://www.drugtargetreview.com/spns1-mutations-reveal-new-lysosomal-lipid-recycling-pathway/679394.article 2026-04-07T10:41:45.153Z https://www.drugtargetreview.com/new-ucla-drug-could-restore-heart-and-organ-function/679408.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/hiv-antibody-04a06-almost-neutralises-all-strains/679439.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/from-war-rooms-to-launch-rooms-how-ai-is-changing-the-game/679450.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/how-smoking-and-alcohol-shape-mutations-in-our-dna/679460.article 2026-03-13T12:10:46.787Z https://www.drugtargetreview.com/new-gene-therapy-restores-brain-function-in-syngap1-disorder/679475.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/the-predictive-validity-crisis-pharmas-productivity-paradox-part-i/679503.article 2026-04-02T15:18:37.863Z https://www.drugtargetreview.com/dna-repair-secrets-of-naked-mole-rats-may-guide-new-drug-discovery/679512.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/the-predictive-validity-crisis-pharmas-productivity-paradox-part-ii/679513.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/darg-cells-may-drive-neurodegeneration-in-progressive-ms/679552.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/sperm-switch-discovery-could-lead-to-new-fertility-therapies/679560.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/how-nanocarriers-and-vlps-are-uniting-to-fight-cancer/679581.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/how-medications-in-waterways-are-encouraging-antibiotic-resistance/679597.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/meta-flux-expands-ai-platform-to-speed-up-drug-development/679613.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/improving-brain-resilience-rab-proteins-and-future-treatments/679627.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/spiral-device-offers-safer-smarter-drug-delivery-to-the-brain/679640.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/how-real-world-data-is-accelerating-drug-discovery/679656.article 2026-04-07T10:38:03.610Z https://www.drugtargetreview.com/from-wild-fungi-to-faster-drug-discovery/679664.article 2026-04-07T10:34:35.450Z https://www.drugtargetreview.com/stem-cell-liver-model-reproduces-rare-immune-drug-reactions/679683.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/building-reliable-organoid-models-for-human-relevant-drug-discovery/679707.article 2026-04-07T10:37:01.003Z https://www.drugtargetreview.com/new-mrna-therapy-could-inform-future-male-infertility-treatments/679727.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/enzyme-papb-could-boost-diabetes-and-obesity-peptide-drugs/679749.article 2026-03-12T15:34:25.173Z https://www.drugtargetreview.com/pulmonary-fibrosis-new-drug-slows-and-reverses-lung-scarring/679756.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/brains-circhomer1-rna-offers-insights-for-future-neurological-treatments/679797.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/new-compound-blend-reverses-sugar-damage-to-tackle-ageing-and-obesity/679808.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/when-chemistry-corrects-biology-the-deuterated-return-of-a-met-inhibitor/679832.article 2026-04-07T10:33:07.993Z https://www.drugtargetreview.com/cd24-emerges-as-the-next-macrophage-checkpoint/679839.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/il-2-and-glp-1-receptor-agonist-combination-tackles-neuroinflammation/679849.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/how-ai-and-cell-data-combine-to-make-drug-discovery-faster/679880.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/new-pet-tracer-could-lead-to-better-als-and-alzheimers-diagnosis/679889.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/swallowable-bioluminescent-pill-detects-early-signs-of-gut-ischaemia/679904.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/trf1-protein-identified-as-potential-obesity-drug-target/679913.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/overactive-neurons-linked-to-schizophrenia-like-behaviour/679932.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/nasal-drug-delivery-the-non-invasive-future-of-treatment/679950.article 2026-04-02T07:49:01.593Z https://www.drugtargetreview.com/new-antibiotic-discovery-could-help-tackle-antimicrobial-resistance/679957.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/targeting-fibroblasts-could-lead-to-new-heart-failure-therapies/679980.article 2026-03-13T12:13:36.773Z https://www.drugtargetreview.com/crispr-epigenetic-switch-provides-new-way-to-control-memory/679996.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/existing-nerve-pain-drugs-may-help-stop-bone-cancer-spread/680009.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/whats-changing-in-cancer-drug-discovery-and-why-it-matters-now/680027.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/reports/lab-automation-where-discovery-scales/680043.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/deep-data-not-big-data/680067.article 2026-04-02T07:44:00.530Z https://www.drugtargetreview.com/beyond-weight-loss-the-gap-in-current-drug-development-for-obesity/680074.article 2026-03-12T16:05:33.077Z https://www.drugtargetreview.com/alzheimers-brain-structure-investigated-through-fruit-flies/680085.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/new-blood-test-detects-alzheimers-years-before-symptoms/680124.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/lab-grown-liver-offers-new-platform-to-test-fibrosis-drugs/680141.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/meet-wrprfa-the-precision-peptide-changing-how-we-study-pain/680166.article 2026-03-12T15:34:25.173Z https://www.drugtargetreview.com/nuclera-expands-into-australasia-with-solve-scientific-partnership/680184.article 2026-03-13T12:11:36.953Z https://www.drugtargetreview.com/resetting-retinal-networks-with-a-gene-agnostic-approach/680199.article 2026-04-02T10:53:09.097Z https://www.drugtargetreview.com/bvra-enzyme-may-slow-down-alzheimers-progression/680215.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/inside-elrig-drug-discovery-2025-automation-ai-and-human-relevant-models/680237.article 2026-03-13T12:11:36.953Z https://www.drugtargetreview.com/rna-folding-new-model-could-change-future-drug-design/680250.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/sugar-coated-tumours-a-new-target-for-pancreatic-cancer/680269.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/tackling-the-organ-shortage-through-vascular-bioengineering/680275.article 2026-03-12T15:12:02.060Z https://www.drugtargetreview.com/recombinant-klk1-the-next-step-in-stroke-and-preeclampsia-treatment/680279.article 2026-04-01T15:07:23.220Z https://www.drugtargetreview.com/protein-fsp1-found-to-help-melanoma-survive-in-lymph-nodes/680304.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/alzheimers-may-disrupt-fat-tissue-and-raise-metabolic-disease-risk/680321.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/zuckerbergs-biohub-announces-ai-powered-biology-to-accelerate-drug-discovery/680328.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/why-first-void-urine-could-potentially-change-the-future-of-hpv-screening/680359.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/scientists-use-ai-to-create-antibodies-entirely-from-scratch/680363.article 2026-03-13T12:09:00.693Z https://www.drugtargetreview.com/glp-1-weight-loss-drugs-may-protect-against-pancreatitis/680397.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/dna-genotek-inc/680406.article 2026-03-05T11:58:58.230Z https://www.drugtargetreview.com/tr-receptor-could-be-key-to-slowing-prostate-cancer/680417.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/ai-and-the-future-of-biomarker-analysis-in-early-randd/680428.article 2026-04-02T07:46:23.700Z https://www.drugtargetreview.com/how-a-psychedelic-found-in-mushrooms-could-help-fight-alcoholism/680446.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/uk-government-announce-plans-to-phase-out-animal-testing-for-drugs/680470.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/next-gen-mri-agents-improve-stability-and-effectiveness/680494.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/parp14-the-human-gene-that-fights-against-herpes-and-covid/680542.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/new-framework-enhances-reliability-of-virtual-cell-models/680554.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/circular-rna-technology-the-future-of-gene-therapy/680567.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/how-antibody-drug-conjugates-are-improving-gynaecological-cancer-outcomes/680575.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/new-study-shows-ageing-may-help-prevent-cancer-growth/680587.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/advancing-disease-biomarker-research-with-ev-multiplex-profiling/680607.article 2026-04-02T07:35:00.530Z https://www.drugtargetreview.com/ai-and-policy-reform-set-to-reshape-uk-drug-development/680616.article 2026-04-07T10:46:32.560Z https://www.drugtargetreview.com/fgd3-protein-enhances-breast-cancer-therapies/680623.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/making-science-run-at-the-speed-of-thought-the-reality-of-ai-in-drug-discovery-part-1/680632.article 2026-04-02T07:42:25.407Z https://www.drugtargetreview.com/making-science-run-at-the-speed-of-thought-the-reality-of-ai-in-drug-discovery-part-2/680638.article 2026-04-02T07:42:36.540Z https://www.drugtargetreview.com/nasal-hpv-vaccine-could-replace-surgery-for-cervical-cancer/680645.article 2026-03-12T14:26:39.930Z https://www.drugtargetreview.com/mapping-the-genome-in-3d-to-reveal-new-drug-targets/680646.article 2026-04-07T10:27:43.653Z https://www.drugtargetreview.com/scripta-therapeutics-raises-12m-to-advance-neurodegenerative-research/680682.article 2026-03-12T14:19:37.480Z https://www.drugtargetreview.com/crispr-disruption-of-nrf2-re-sensitises-tumours-to-chemo/680699.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/rvx-001-a-universal-vaccine-to-tackle-antimicrobial-resistance/680702.article 2026-04-07T10:31:38.940Z https://www.drugtargetreview.com/deeptarget-tool-helps-identify-secondary-cancer-drug-targets/680717.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/bacterial-traces-discovered-within-gliomas-and-brain-metastases/680732.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/the-mother-of-invention-from-steam-engines-to-ai-designed-drugs/680739.article 2026-04-02T07:25:17.267Z https://www.drugtargetreview.com/pdx-models-a-new-tool-for-colorectal-cancer-research/680758.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/transforming-central-labs-with-automation-and-ai-setting-new-standards-for-modern-trials/680766.article 2026-04-02T07:40:23.847Z https://www.drugtargetreview.com/recycled-nuclear-fuel-to-power-new-cancer-treatments-in-the-uk/680784.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/new-car-t-cell-therapy-capable-of-destroying-glioblastoma-cells/680792.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/new-stealth-crispr-method-reduces-immune-interference-in-tumours/680813.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/blood-stem-cell-and-islet-cell-transplant-combo-reverses-type-1-diabetes/680827.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/fast-scalable-free-energy-prediction-with-nonequilibrium-switching/680846.article 2026-04-02T07:22:13.650Z https://www.drugtargetreview.com/rna-that-knows-where-to-go-the-rise-of-targeted-delivery/680856.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/redesigning-paclitaxel-expanding-the-therapeutic-window-through-oral-delivery/680864.article 2026-04-07T10:25:42.720Z https://www.drugtargetreview.com/mapping-lipid-pockets-to-drug-the-undruggable-proteome/680873.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/the-partnership-changing-the-pace-of-radiopharmaceutical-development/680879.article 2026-04-01T14:55:37.313Z https://www.drugtargetreview.com/oral-arginine-reduces-harmful-amyloid-in-alzheimers-models/680891.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/dexamethasone-may-halt-metastases-in-resistant-breast-cancer/680913.article 2026-03-12T14:21:35.840Z https://www.drugtargetreview.com/rhosin-shown-to-reverse-blood-stem-cell-ageing/680920.article 2026-03-12T14:21:35.840Z https://www.drugtargetreview.com/otulin-enzyme-found-to-control-tau-production-in-alzheimers/680936.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/logic-gated-darpins-show-targeted-t-cell-activation-in-tumours/680948.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/samsung-invests-in-phrontline-to-advance-next-gen-adc-therapies/680959.article 2026-03-12T14:21:35.840Z https://www.drugtargetreview.com/targeting-p300-may-boost-immunotherapy-in-kidney-cancer/680970.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/new-mrna-therapy-targets-drug-resistant-pneumonia/680978.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/kinase-inhibitors-shown-to-accelerate-protein-breakdown/680992.article 2026-03-12T13:11:30.807Z https://www.drugtargetreview.com/why-tigit-cancer-therapies-work-in-monkeys-but-not-humans/681003.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/pre-transplant-treg-therapy-reduces-gvhd-risk-for-blood-cancer-patients/681013.article 2026-03-13T12:13:36.773Z https://www.drugtargetreview.com/protein-folding-interference-a-new-path-to-hard-to-drug-targets/681026.article 2026-04-02T13:32:03.557Z https://www.drugtargetreview.com/kidney-fibrosis-linked-to-overactive-hippo-signalling-pathway/681030.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/new-car-nkt-treatment-destroys-metastatic-pancreatic-tumours/681088.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/romidepsin-drug-combo-proves-effective-against-resistant-childhood-cancer/681099.article 2026-03-12T16:11:23.180Z https://www.drugtargetreview.com/ai-powers-discovery-of-new-cblb-inhibitor-ism3830/681133.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/rna-that-lasts-longer-and-lands-exactly-where-it-should/681147.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/researchers-identify-new-drug-site-on-epilepsy-target-sv2a/681157.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/automated-lung-organoids-to-speed-up-new-drug-development/681183.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/bits2bonds-ai-system-accelerates-discovery-of-rna-delivery-polymers/681190.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/estrone-hormone-linked-to-deadly-breast-cancer-in-obese-women/681196.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/fibulin-5-linked-to-early-detection-of-liver-fibrosis/681210.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/building-better-biologics-and-a-stronger-future-for-women-in-stem/681215.article 2026-04-01T14:43:42.280Z https://www.drugtargetreview.com/myc-inhibitor-omomyc-boosts-parp-drug-response-in-breast-cancer/681223.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/new-organ-on-a-chip-models-ageing-immune-response-for-cancer-vaccines/681244.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/blocking-the-p2x4-receptor-a-potential-pathway-to-new-therapies/681265.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/the-future-of-obesity-drugs-starts-in-preclinical-discovery/681277.article 2026-04-02T13:30:31.760Z https://www.drugtargetreview.com/ty1-new-experimental-drug-restores-tissue-after-heart-attack/681292.article 2026-03-12T14:21:35.840Z https://www.drugtargetreview.com/life-sciences-face-scientific-content-crisis-in-ai-adoption/681361.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/live-cell-liquid-biopsy-study-aims-to-transform-cancer-treatment/681373.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/new-beta-lab-platform-to-streamline-early-stage-research/681409.article 2026-03-12T13:11:30.807Z https://www.drugtargetreview.com/new-reverse-genetic-system-accelerates-norovirus-vaccine-research/681419.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/platelet-inspired-nanoparticles-could-improve-treatment-of-inflammatory-diseases/681429.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/new-spheromatrix-platform-speeds-up-cancer-drug-research/681445.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/inhibiting-ddr1-pathway-helps-breach-pancreatic-cancers-drug-barrier/681471.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/ai-powered-ckd-drug-ism4808-licensed-for-kidney-disease-therapy/681486.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/fertility-gene-prdm9-linked-to-relapse-in-glioblastoma/681526.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/cbd-and-thc-show-anti-cancer-effects-against-ovarian-tumours/681534.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/new-ai-model-links-genetic-mutations-to-specific-diseases/681555.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/hydrogel-tech-enables-global-shipping-of-organoid-models/681573.article 2026-04-13T13:35:20.167Z https://www.drugtargetreview.com/why-patient-derived-biology-matters-for-adc-discovery/681605.article 2026-04-01T14:43:20.477Z https://www.drugtargetreview.com/brain-drainage-repair-offers-potential-new-prevention-therapies-for-alzheimers/681616.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/scientists-discover-potential-therapy-for-pancreatic-cancer-induced-cachexia/681625.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/parkinsons-new-study-rethinks-dopamines-role-in-movement/681651.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/ultra-stable-hydrogel-boosts-gastrointestinal-wound-repair/681658.article 2026-03-13T12:13:36.773Z https://www.drugtargetreview.com/new-method-preserves-ips-cells-for-regenerative-medicine/681665.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/tiny-rna-molecule-helps-viruses-hijack-bacterial-cells/681693.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/experimental-drug-nu-9-reduces-toxic-amyloid-in-early-alzheimers/681700.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/new-study-identifies-genetic-weakness-in-deadly-candida-auris-fungus/681712.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/new-research-aims-to-make-fda-approved-drugs-safer-for-the-brain/681750.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/engineered-extracellular-vesicles-control-immune-responses/681778.article 2026-03-13T12:13:36.773Z https://www.drugtargetreview.com/homer1-gene-discovery-could-lead-to-new-adhd-therapies/681782.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/blocking-paf-receptor-could-offer-new-liver-cirrhosis-treatment/681792.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/peptides-in-practice-what-it-takes-to-advance-these-therapies-to-clinic/681795.article 2026-04-02T13:28:04Z https://www.drugtargetreview.com/brain-master-switch-discovery-could-lead-to-new-neurodegenerative-therapies/681816.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/slas2025-international-conference-and-exhibition/645264.article 2026-03-05T17:01:46.577Z https://www.drugtargetreview.com/advancing-obesity-drug-discovery-cell-based-assays-for-glp-1-and-the-g-suite/645291.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/the-rise-of-organoids-a-new-era-in-drug-discovery/645459.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/aaps-national-biotechnology-conference/645600.article 2026-03-05T17:01:46.577Z https://www.drugtargetreview.com/the-future-of-carcinogenicity-risk-assessment-ai-powered-ethical-alternatives-to-traditional-testing/645713.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/advanced-therapies-uk/646831.article 2026-03-05T17:01:46.577Z https://www.drugtargetreview.com/aaps-summer-scientific-forum/647522.article 2026-03-05T17:01:46.577Z https://www.drugtargetreview.com/reprogramming-immunity-designing-smarter-checkpoint-receptor-agonists/648134.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/solving-the-aoc-puzzle-strategies-for-chemistry-manufacturing-and-regulatory-success/648235.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/smarter-labs-faster-results-the-power-of-automation-in-drug-discovery/648741.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/advancing-adc-development-end-to-end-solutions-from-design-to-characterization/649032.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/ai-powered-drug-discovery-accelerating-the-development-of-life-saving-therapies/649468.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/webinars/cancer-drug-discovery-breakthroughs-research-thats-changing-lives/649475.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/unlocking-high-throughput-biology-in-drug-discovery-symposium/650075.article 2026-03-05T17:01:46.577Z https://www.drugtargetreview.com/unlocking-high-throughput-biology-in-drug-discovery-symposium/650116.article 2026-03-05T17:01:46.577Z https://www.drugtargetreview.com/optimizing-antibody-leads-in-early-drug-discovery-with-key-developability-insights/654279.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/early-de-risking-in-vitro-safety-strategies-for-pre-ind-success/659266.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/innovating-obesity-drug-discovery-trends-challenges-and-translational-strategies/669079.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/visit-the-worlds-leading-show-for-the-lab-industry-analytica-usa/669546.article 2026-03-05T17:01:46.577Z https://www.drugtargetreview.com/drug-discovery-2025-a-festival-of-life-science/670556.article 2026-03-05T17:01:46.577Z https://www.drugtargetreview.com/webinars/overcoming-affinity-and-expression-bottlenecks-in-tcr-discovery/671469.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/webinars/can-one-peptide-change-pain-research-meet-the-tool-transforming-drug-discovery/676189.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/17th-annual-pegs-europe/679785.article 2026-03-05T17:01:46.577Z https://www.drugtargetreview.com/the-truth-about-ai-in-drug-discovery-what-the-experts-really-think/681559.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/aaps-national-biotechnology-conference/681747.article 2026-03-12T12:24:02.483Z